EUPHORBIACEAE Phyllanthus emblica  L.

 Synonym

  • EUPHORBIACEAE Emblica officinalis  Gaertn.
 Thai / English name

  • มะขามป้อม*

[1-1] of 1 article(s) found

 หน้า  1  

[1] STUDY OF PHARMACODYNAMIC INTERACTION OF PHYLLANTHUS EMBLICA EXTRACT WITH CLOPIDOGREL AND ECOSPRIN IN PATIENTS WITH TYPE II DIABETES MELLITUS.
NISHAT FATIMA, USHARANI PINGALI, N. MURALIDHAR
PHYTOMEDICINE 2014 Vol.21(),579-85  $50088 [Full]

Part Used : ผล
Activity : DRUG INTERACTION
Solvent/Active Compound : Phyllanthus emblica extract
Type of experiment : human
Type of animal : -
Type of study : Open trial
N(Total) : 10* (M/F = 6/4)
N(Treatment) : 10 (M/F = 6/4)
Sex : Both sex
Age : 58.60+/-10.54 yrs.
Route : Oral administration
Dose/Conc.(herb) : single dose of 500 mg Phyllanthus emblica extract + 75 mg clopidogrel
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : Clopidogrel
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: Combination therapy produced a significant decrease of platelet aggregation after 4 h of treatment, compared to baseline. The percentage inhibition with the combination of P. emblica + clopidogrel was 49.78%.
Note : *Subject total: Subjects were type II diabetic patients. Conclusion: P. emblica extract demonstrated significant antiplatelet activity with both single and multiple dose administration.

Part Used : ผล
Activity : DRUG INTERACTION
Solvent/Active Compound : Phyllanthus emblica extract
Type of experiment : human
Type of animal : -
Type of study : Cross over
N(Total) : 10* (M/F = 6/4)
N(Treatment) : 10 (M/F = 6/4)
Sex : Both sex
Age : 58.60+/-10.54 yrs.
Route : Oral administration
Dose/Conc.(herb) : single dose of 500 mg Phyllanthus emblica extract + 75 mg clopidogrel
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : Clopidogrel
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: Combination therapy produced a significant decrease of platelet aggregation after 4 h of treatment, compared to baseline. The percentage inhibition with the combination of P. emblica + clopidogrel was 49.78%.
Note : *Subject total: Subjects were type II diabetic patients. Conclusion: P. emblica extract demonstrated significant antiplatelet activity with both single and multiple dose administration.

Part Used : ผล
Activity : DRUG INTERACTION
Solvent/Active Compound : Phyllanthus emblica extract
Type of experiment : human
Type of animal : -
Type of study : Open trial
N(Total) : 10* (M/F = 6/4)
N(Treatment) : 10 (M/F = 6/4)
Sex : Both sex
Age : 58.60+/-10.54 yrs.
Route : Oral administration
Dose/Conc.(herb) : 500 mg P. emblica extract twice daily + 75 mg clopidogrel once daily
Duration : 10 days.
Type of interaction : Pharmacodynamics
Interaction with drug : Clopidogrel
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: Ten days treatment produced significant decrease of platelet aggregation compared to baseline. The mean percent inhibition of platelet aggregation on multiple dose administration dose administration with combination P. emblica + clopidogrel 75 mg was 53.42%. There was statistically significant change observed when combination treatments were compared to P. emblica alone. Though there was apparent increase in inhibition of platelet aggregation with P. emblica + clopidogrel Vs clopidogrel alone, this difference was not however statistically significant.
Note : *Subject total: Subjects were type II diabetic patients. Conclusion: P. emblica extract demonstrated significant antiplatelet activity with both single and multiple dose administration.

Part Used : ผล
Activity : DRUG INTERACTION
Solvent/Active Compound : Phyllanthus emblica extract
Type of experiment : human
Type of animal : -
Type of study : Cross over
N(Total) : 10* (M/F = 6/4)
N(Treatment) : 10 (M/F = 6/4)
Sex : Both sex
Age : 58.60+/-10.54 yrs.
Route : Oral administration
Dose/Conc.(herb) : 500 mg P. emblica extract twice daily + 75 mg clopidogrel once daily
Duration : 10 days.
Type of interaction : Pharmacodynamics
Interaction with drug : Clopidogrel
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: Ten days treatment produced significant decrease of platelet aggregation compared to baseline. The mean percent inhibition of platelet aggregation on multiple dose administration dose administration with combination P. emblica + clopidogrel 75 mg was 53.42%. There was statistically significant change observed when combination treatments were compared to P. emblica alone. Though there was apparent increase in inhibition of platelet aggregation with P. emblica + clopidogrel Vs clopidogrel alone, this difference was not however statistically significant.
Note : *Subject total: Subjects were type II diabetic patients. Conclusion: P. emblica extract demonstrated significant antiplatelet activity with both single and multiple dose administration.


 หน้า  1